Additionally, similar to the intrinsically venetoclax-resistant DLBCL lines, there was a decrease in BAK protein in all three acquired venetoclax-resistant DLBCL lines (Figure 1F), which has an essential role in executing apoptosis and is typically not evaluated [10]. The gene discussed is BAK1; the disease is diffuse large B-cell lymphoma.